Cassava Sciences reported $-0.22 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Abbott USD 1.5 0.2 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
Cara Therapeutics USD -5.04 3.24 Dec/2024
Cassava Sciences USD -0.22 0.7 Sep/2025
Eisai JPY 60.94 24.92 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Geron USD -0.05 0.02 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Novavax USD -0.76 1.76 Sep/2024
Pfizer USD 0.66 0.21 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025